Search Results 51-60 of 17312 for Teratogenic

  1. Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities. - Mayo Clinic

    ... teratogenic effects: -Pregnant women -Nursing women -Women of childbearing potential who are unwilling to employ adequate contraception -Co-morbid systemic ...

  2. A Study to Evaluate Feasibility of In Vivo Sensitivity Screen Using Direct Tumor Microinjection and FDG-PET in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer - Mayo Clinic

    Any of the following because this study involves an investigational agent that is genotoxic, mutagenic and teratogenic effects on the developing fetus and ...

  3. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

    For this reason and because DNA-damage response inhibitors as well as other therapeutic agents used in this trial are known to be teratogenic, women of ...

  4. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

    ... teratogenic effects: * Pregnant women * Nursing women * Men or women of childbearing potential who are unwilling to employ adequate contraception * Co ...

  5. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    For this reason, and because the study drugs used in this trial are known to be teratogenic, females of child-bearing potential must agree to use adequate ...

  6. Hypertrophic cardiomyopathy - Doctors and departments - Mayo Clinic

    In this condition, the heart muscle thickens, which makes it harder for the heart to pump blood. Learn about the causes and treatment.

  7. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Pregnant women are excluded from this study because XL184 (cabozantinib) has the potential for teratogenic or abortifacient effects, and the effects of ...

  8. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

    ... teratogenic effects on the developing fetus and newborn are unknown: * Pregnant women * Nursing women unwilling to stop breast feeding * Women of child ...

  9. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

    Pregnant women are excluded from this study because ibrutinib is a tyrosine kinase inhibitor with the potential for teratogenic or abortifacient effects.

  10. A Study Of BMS-986340 In Combination With Nivolumab, Gemcitabine And Nab-paclitaxel In The First Line Setting Of Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Any of the following because this study involves an agent that has known genotoxic mutagenic and teratogenic effects: Pregnant persons. Nursing persons. Women ...